Dutta Sanjucta, Jacobs Michael R, Good Caryn E, Abdelhamed Ayman M, Ying Yun C, Hoyos-Urias Adrian, Sugui Derrick J, Anaeto Jacqueline U, Deak Eszter, Valdez Rachael, Rajan Nitin K, Herget Meike S, Riedel Stefan
Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Harvard Medical School, Boston, Massachusetts, USA.
J Clin Microbiol. 2025 Jun 11;63(6):e0160624. doi: 10.1128/jcm.01606-24. Epub 2025 May 9.
Bloodstream infections frequently cause sepsis, a condition that can lead to organ dysfunction and death. Rapid antimicrobial susceptibility testing (AST) results are critical for appropriate medical intervention and to either de-escalate or escalate antibiotics to appropriate therapy. We describe the results from a multicenter clinical study evaluating the performance of the eQUANT system (Avails Medical, Inc., Menlo Park, CA). The eQUANT system generates a 0.5 McFarland equivalent suspension, the eMcFarland, directly from a positive blood culture bottle for use with downstream disk diffusion AST, thereby saving up to 24 hours compared to traditional AST workflow. A combination of fresh, prospectively collected clinical (42) and contrived (525) blood cultures were tested, and results for disk diffusion using the Avails eQUANT eMcFarland suspension as the inoculum were compared to disk diffusion results the next day using the standard 0.5 McFarland suspension prepared from plate subculture. Thirteen species of gram-negative rods were evaluated against 12 antibiotics. From the 2,679 pairs of AST results, overall categorical agreement was 95.0%. Overall very major errors, major errors, and minor errors were 0.15%, 0.60%, and 4.48%, respectively. The Avails eQUANT system has the potential to significantly accelerate the standard of care by eliminating the need for subculture.IMPORTANCERapid reporting of antimicrobial susceptibility test results for bacterial isolates from blood cultures is critical for timely implementation of optimal antimicrobial therapy and improves outcomes of sepsis patients. In this study, we demonstrate the accuracy and performance characteristics of the eQUANT system, which generates a 0.5 McFarland equivalent suspension, the eMcFarland, directly from a positive blood culture bottle for use with downstream disk diffusion antimicrobial susceptibility testing (AST). Using the eMcFarland suspension allows for accurate and standardized reporting of disk diffusion AST results from positive blood cultures.
血流感染常导致脓毒症,这种情况可导致器官功能障碍和死亡。快速抗菌药物敏感性试验(AST)结果对于适当的医疗干预以及将抗生素降级或升级至适当治疗至关重要。我们描述了一项多中心临床研究的结果,该研究评估了eQUANT系统(Avails Medical,Inc.,加利福尼亚州门洛帕克)的性能。eQUANT系统可直接从阳性血培养瓶中生成0.5麦氏浊度当量的悬液,即e麦氏浊度,用于下游纸片扩散法AST,与传统AST工作流程相比,可节省多达24小时。对新鲜的、前瞻性收集的临床血培养(42份)和人工血培养(525份)进行了组合测试,并将使用Avails eQUANT e麦氏浊度悬液作为接种物的纸片扩散法结果与第二天使用平板传代培养制备的标准0.5麦氏浊度悬液的纸片扩散法结果进行了比较。对13种革兰氏阴性杆菌针对12种抗生素进行了评估。在2679对AST结果中,总体分类一致性为95.0%。总体极重大错误、重大错误和轻微错误分别为0.15%、0.60%和4.48%。Avails eQUANT系统有可能通过消除传代培养的需要而显著加快护理标准。重要性对于血培养中分离出的细菌进行抗菌药物敏感性试验结果的快速报告对于及时实施最佳抗菌治疗以及改善脓毒症患者的预后至关重要。在本研究中,我们证明了eQUANT系统的准确性和性能特征,该系统可直接从阳性血培养瓶中生成0.5麦氏浊度当量的悬液,即e麦氏浊度,用于下游纸片扩散法抗菌药物敏感性试验(AST)。使用e麦氏浊度悬液可准确、标准化地报告来自阳性血培养的纸片扩散法AST结果。